category

Floor Show

Biogen shares slip as Alzheimer's drug faces new setback

Shares of Biogen slipped nearly 4% in pre-market trading Wednesday after the biotech company's new Alzheimer's drug Aduhelm (aducanumab) received a "negative trend vote" from the European Medicine Agency's Committee for Medicinal Products for Human Use (CHMP).

Stocks just miss records as retail sales jump

U.S. stocks rallied to just shy of record highs Tuesday as traders celebrated a jump in retail sales a day after President Biden signed the $1.2 trillion bipartisan infrastructure bill.